World

South African Medical Association cuts ties with Israeli counterpart, urges global suspension

Oct 05, 2025

Cape Town [South Africa], October 5: The South African Medical Association (SAMA) has announced its decision to "immediately suspend all professional and bilateral relations" with the Israeli Medical Association (IMA), citing grave concerns over the humanitarian crisis in Gaza and alleged breaches of international medical ethics.
In a statement issued on Saturday, SAMA, which represents doctors across South Africa, said it would also press for the IMA's suspension from the World Medical Association (WMA).
SAMA said that these decisions, adopted on Oct. 3 following what it described as "extensive consultations," reflect the association's view that the IMA has failed to uphold "international medical ethics and humanitarian obligations" in the context of the conflict.
The announcement came shortly after Israel's interception of the Global Sumud Flotilla and the detention of its participants in international waters as they attempted to deliver humanitarian aid to Gaza.
In the statement, SAMA said that its decisions would remain in effect until the IMA took "public and verifiable actions," including demanding the release of detained Palestinian medical personnel, condemning the destruction of Gaza's healthcare system, denouncing the use of starvation as a policy and the blockade of essential medical supplies, and taking active measures to ensure adequate medical care for all individuals under Israeli control.
"These resolutions reflect SAMA's commitment to upholding medical ethics, human rights and the sanctity of healthcare work in conflict situations," the organization said, adding that its stance aligns with the principles of the WMA and international humanitarian law.
Source: Xinhua News Agency

More news

Infosys: Differentiated AI strategy and a sharp focus on value unlock propels 29% sequential growth in AI revenues

Bengaluru (Karnataka) [India], October 23: Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in AI-first business consulting and technology services, delivered $5,145 million in Q2 revenues, year on year growth of 1.5% and sequential growth of 1.2% in constant currency. Operating margin was stable at 21.0%. EPS growth was 8.7% year on year in rupee terms. TCV of large deal wins was $5.2 billion, with 62% net new. Robust Q2 large deal TCV at $5.2 billion with 62% net new; lays solid foundation for future growth. FY 27 revenue guidance revised to 1%-2% and margin guidance retained at 20%-22%.

Oct 23, 2026